|
Fibrosis-targeting drugs may benefit patients with late-stage, metastatic breast canc
A Massachusetts General Hospital (MGH) research team has found that the overgrowth of connective called fibrosis may block the effectiveness of immunotherapies against metastatic breast cancer.
More... |